Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Merz Strengthens Partnership With Start-up Vensica and Invests up to $3 million
Details : This investment follows the strategic license and collaboration agreement signed in 2021 to utilize Merz’s botulinum neurotoxin A (XEOMIN®) for the innovative ultrasound-assisted delivery catheter of Vensica.
Product Name : Xeomin
Product Type : Protein
Upfront Cash : Undisclosed
July 02, 2022
Reset All
